<VariationArchive VariationID="1072682" VariationName="NC_000011.9:g.(?_31804921)_(31816377_?)del" VariationType="Deletion" Accession="VCV001072682" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-01" DateCreated="2021-05-10" MostRecentSubmission="2021-05-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1057535" VariationID="1072682">
      <GeneList>
        <Gene Symbol="ELP4" FullName="elongator acetyltransferase complex subunit 4" GeneID="26610" HGNC_ID="HGNC:1171" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="31509767" stop="31790324" display_start="31509767" display_stop="31790324" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="31531296" stop="31805328" display_start="31531296" display_stop="31805328" Strand="+" />
          </Location>
          <OMIM>606985</OMIM>
        </Gene>
        <Gene Symbol="PAX6" FullName="paired box 6" GeneID="5080" HGNC_ID="HGNC:8620" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="31789026" stop="31817961" display_start="31789026" display_stop="31817961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="31806339" stop="31839508" display_start="31806339" display_stop="31839508" Strand="-" />
          </Location>
          <OMIM>607108</OMIM>
          <Haploinsufficiency last_evaluated="2015-11-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX6">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-11-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX6">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000011.9:g.(?_31804921)_(31816377_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" innerStart="31804921" innerStop="31816377" display_start="31804921" display_stop="31816377" variantLength="11457" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(?_31804921)_(31816377_?)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(?_31804921)_(31816377_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.9:g.(?_31804921)_(31816377_?)del AND multiple conditions" Accession="RCV001385452" Version="1">
        <ClassifiedConditionList TraitSetID="39839">
          <ClassifiedCondition DB="MedGen" ID="C0344542">Aniridia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0344559">Irido-corneo-trabecular dysgenesis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-04-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-04-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2021-05-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18483559</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="39839" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="315" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aniridia 1</ElementValue>
                <XRef ID="MONDO:0024507" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AN1</ElementValue>
                <XRef Type="MIM" ID="106210" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ &lt;74) is observed in 70%; behavioral abnormalities include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral problems.</Attribute>
                <XRef ID="NBK1360" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301534</ID>
                <ID Source="BookShelf">NBK1360</ID>
              </Citation>
              <XRef ID="250923" DB="Orphanet" />
              <XRef ID="C0344542" DB="MedGen" />
              <XRef ID="MONDO:0024507" DB="MONDO" />
              <XRef Type="MIM" ID="106210" DB="OMIM" />
            </Trait>
            <Trait ID="3486" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Irido-corneo-trabecular dysgenesis</ElementValue>
                <XRef ID="Irido-corneo-trabecular+dysgenesis/8682" DB="Genetic Alliance" />
                <XRef ID="204153003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ANTERIOR SEGMENT DYSGENESIS 5</ElementValue>
                <XRef Type="MIM" ID="604229" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ASGD5</ElementValue>
                <XRef Type="MIM" ID="604229" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7377" />
                <XRef ID="7377" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="708" DB="Orphanet" />
              <XRef ID="C0344559" DB="MedGen" />
              <XRef ID="MONDO:0011414" DB="MONDO" />
              <XRef Type="MIM" ID="604229" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000659" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3110944" SubmissionDate="2021-01-07" DateLastUpdated="2021-05-10" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_000280.4_11_Deletion (exons 8-13)|MedGen:C0344542;C0344559" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001585298" DateUpdated="2021-05-10" DateCreated="2021-05-10" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18483559</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exons 8-13 of the PAX6 gene. The 5' boundary is likely confined to intron 7. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. Gross deletions of exons 8-13 has been observed in individuals affected with aniridia (PMID: 18483559, Invitae). This deletion has been described in the literature as deletions of exons 9-14 based on alternative exon numbering. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.(?_31804921)_(31816377_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0344542" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0344559" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3110944" TraitType="Disease" MappingType="XRef" MappingValue="C0344559" MappingRef="MedGen">
        <MedGen CUI="C0344559" Name="Irido-corneo-trabecular dysgenesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3110944" TraitType="Disease" MappingType="XRef" MappingValue="C0344542" MappingRef="MedGen">
        <MedGen CUI="C0344542" Name="Aniridia 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

